Although numerous studies have demonstrated the potential benefits of ChEIs, the use of these drugs in clinical practice has not been well described and may differ from that in clinical trials. In ...

Drugs that are used for treating Alzheimer's disease in its early stages are linked to a reduced risk of heart attacks and death, according to a large study of over 7,000 people with Alzheimer's ...

Background: Cholinesterase inhibitors (ChEIs) are the only drugs marketed for the treatment of Alzheimer's disease. Despite numerous randomized controlled trials, the efficacy and safety of this group ...

Concomitant use of cholinesterase inhibitors (ChEIs) or memantine are tied to a faster rate of cognitive decline in patients participating in Alzheimer's disease (AD) trials, a new meta-analysis ...

Lewy body disease is a stealthy and relentless brain disorder that affects memory, movement, and core body functions. It includes dementia with Lewy bodies and Parkinson’s disease, with or without ...

Please provide your email address to receive an email when new articles are posted on . Cholinesterase inhibitors provided moderate but persistent benefits in patients with Alzheimer’s dementia, ...

A study evaluating the risk of overactive bladder as a side effect of cholinesterase inhibitor drugs taken for dementia and Alzheimer's disease, finds that one drug -- Donepezil -- is linked to ...

Alzheimer’s dementia represents organ failure of the brain. It denotes a clinical milestone that is the result of a pathological process, Alzheimer’s disease (AD), which over 1 or more decades has ...